Dr. Kalub Alexander Fedak, MD

Dr. Fedak practices at McLaren Central Michigan in Mount Pleasant, Michigan, part of McLaren Health Care.

Dr. Fedak's NPI, 1225353139, was assigned on April 2, 2010. Dr. Fedak graduated from College of Human Medicine - Grand Rapids in 2010. Dr. Fedak holds Michigan license 4301104179.

Dr. Fedak's primary practice is McLaren Central Michigan, at 1221 South Drive, Mount Pleasant, MI 48858 in Isabella County. The practice phone is (989) 772-6700.

Dr. Fedak's primary practice is McLaren Central Michigan in Mount Pleasant, Michigan, part of McLaren Health Care. Dr. Fedak is also affiliated with Munson Healthcare Otsego Memorial Hospital. The medical group on file is McLaren Central Michigan. Dmand AI also links Dr. Fedak to 3 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account. Dr. Fedak's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fedak practices, 8 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Fedak's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Fedak is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Fedak's licenses on file in 2 states: Michigan and Ohio.

Dmand AI lists breast cancer, chronic anemia, deep vein thrombosis (DVT), immune deficiency disease, lung cancer, neutropenia and purpura and thrombocytopenia among the conditions Dr. Fedak treats.

CMS data shows 143 Medicare services from Dr. Fedak across 3 procedure codes in 2024, for 84 Medicare patients. Medicare paid $12,478 for them.

CMS counts 84 Medicare patients who saw Dr. Fedak in 2024. The largest group is 65 to 74, with 40 patients. 75% of them have high blood pressure, and 67% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fedak's median patient age at 72, with 47% women.

In 2024, Dr. Fedak wrote 1,302 Medicare Part D claims for 241 patients. 80% of them were for generic drugs. CMS names the drug for 964 of them, across 31 drugs with 11 or more claims each, at $1,986,799 in total drug cost. In 2023, CMS named 709 claims across 23 drugs.

Dr. Fedak accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fedak as offering telehealth.

Dmand AI links 5 papers to Dr. Fedak, published from 2011 to 2023. 2021 was the busiest year, with 2. Dr. Fedak's most frequent co-authors are Surafel Kebede Gebreselassie, MD, Samer Alkassis and Fares Alsawah, MD.

CMS Open Payments shows 73 general payments to Dr. Fedak from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. Janssen Pharmaceuticals, Inc paid the most, $566.

Dr. Fedak graduated from College of Human Medicine - Grand Rapids in 2010. Dr. Fedak is a member of ASCO and ASH.

Dr. Fedak is in network with 10 carriers, including Aetna, Health Alliance Plan and Priority Health. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.